Compare MiniMed Group Inc. Common Stock (MMED) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MiniMed Group Inc. Common Stock vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? MiniMed Group Inc. Common Stock trades at $19.71 (market cap $5.57B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: MiniMed Group Inc. Common Stock is far larger — about 2.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and MiniMed Group Inc. Common Stock is more actively traded (23,336,073 versus 4,179,659). Which is the better fit depends on your goals.
| MMED | SLS | |
|---|---|---|
Market Cap | $5.57B | $2.27B |
Volume | 23,336,073 | 4,179,659 |
Sector | Health | Health |
52-Week High | $23.84 | $15.46 |
52-Week Low | $10.80 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $5.37B | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MiniMed Group Inc. Common Stock
MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
